null

SMILES: NC(=N)c1ccc(cc1)C(=O)NCC(=O)N1CCN([C@@H](Cc2ccccc2)C(O)=O)C(=O)[C@@H]1CC(O)=O

InChI Key: InChIKey=KDXGTKAQPXSESN-OYKVQYDMSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50062800   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062800 ((S)-2-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-ace...) Show SMILES NC(=N)c1ccc(cc1)C(=O)NCC(=O)N1CCN([C@@H](Cc2ccccc2)C(O)=O)C(=O)[C@@H]1CC(O)=O Show InChI InChI=1S/C25H27N5O7/c26-22(27)16-6-8-17(9-7-16)23(34)28-14-20(31)29-10-11-30(24(35)18(29)13-21(32)33)19(25(36)37)12-15-4-2-1-3-5-15/h1-9,18-19H,10-14H2,(H3,26,27)(H,28,34)(H,32,33)(H,36,37)/t18-,19?/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	6.10	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia(HEL) cells.				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062800 ((S)-2-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-ace...) Show SMILES NC(=N)c1ccc(cc1)C(=O)NCC(=O)N1CCN([C@@H](Cc2ccccc2)C(O)=O)C(=O)[C@@H]1CC(O)=O Show InChI InChI=1S/C25H27N5O7/c26-22(27)16-6-8-17(9-7-16)23(34)28-14-20(31)29-10-11-30(24(35)18(29)13-21(32)33)19(25(36)37)12-15-4-2-1-3-5-15/h1-9,18-19H,10-14H2,(H3,26,27)(H,28,34)(H,32,33)(H,36,37)/t18-,19?/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	4.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062800 ((S)-2-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-ace...) Show SMILES NC(=N)c1ccc(cc1)C(=O)NCC(=O)N1CCN([C@@H](Cc2ccccc2)C(O)=O)C(=O)[C@@H]1CC(O)=O Show InChI InChI=1S/C25H27N5O7/c26-22(27)16-6-8-17(9-7-16)23(34)28-14-20(31)29-10-11-30(24(35)18(29)13-21(32)33)19(25(36)37)12-15-4-2-1-3-5-15/h1-9,18-19H,10-14H2,(H3,26,27)(H,28,34)(H,32,33)(H,36,37)/t18-,19?/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	4.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of guinea pig platelets by 50% in vitro				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair